Provider

Panelists at DTx East discuss the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold. 

Ifan Evans, director of technology, digital & transformation for the Welsh Government Health and Social Services, says Wales has benefited from being a small system and prioritized tools that have proved popular with patients.

A new analysis of published RCTs did see significant benefits among short-term and single-focus app interventions, but noted that "relatively few high-quality studies have been conducted" in this area.

Digital maturity must be utilized to improve outcomes and manage the pandemic more effectively, claims HIMSS President and CEO Hal Wolf.

Notable's voice-powered assistant was developed to help curb the time doctors spend on charting. 

The 900-participant study uses learnings from Apple's Tueo Health acquisition and could inform the development of a digital biomarker for asthma.

The watch measures oxygen and energy levels, tracks menstrual cycles, and gives insights into running, biking and swimming workouts.

Jan Kimpen, chief medical officer at Philips, says younger healthcare professionals and the impact of COVID-19 are the focuses of the latest "Future Health Index" survey, which offers a vision into the potential of digital transformation.

Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the FDA's role in balancing innovation, regulation and safety during the coronavirus pandemic.

In a recent survey, 67% of consumers and 91% of IT professionals said they'd support a nationwide rollout of contact-tracing apps or other technologies.